• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与中心性浆液性脉络膜视网膜病变相关的全身表现。

Systemic findings associated with central serous chorioretinopathy.

作者信息

Tittl M K, Spaide R F, Wong D, Pilotto E, Yannuzzi L A, Fisher Y L, Freund B, Guyer D R, Slakter J S, Sorenson J A

机构信息

Vitreous, Retina, Macula Consultants of New York, the LuEsther T. Mertz Retina Research Laboratory, Manhattan Eye, Ear, and Throat Hospital, New York 10021, USA.

出版信息

Am J Ophthalmol. 1999 Jul;128(1):63-8. doi: 10.1016/s0002-9394(99)00075-6.

DOI:10.1016/s0002-9394(99)00075-6
PMID:10482095
Abstract

PURPOSE

To determine systemic factors associated with central serous chorioretinopathy.

METHODS

In a retrospective study, 230 consecutive patients with central serous chorioretinopathy examined in a referral setting were compared with a historical gender-matched and age-matched control group of 230 patients with ocular findings who were examined in the same referral setting.

RESULTS

The median age of the patients was 49.8 years, and of the control subjects, 50.0 years. The male-female ratio for both groups was 2.7:1. Patients with central serous chorioretinopathy were more likely to use psychopharmacologic medications (odds ratio = 2.6; 95% confidence interval = 1.30 to 5.19; P = .0049) and corticosteroids (odds ratio = 3.17; 95% confidence interval = 1.30 to 7.70; P = .0067) and were more likely to have hypertension (odds ratio = 2.25; 95% confidence interval = 1.39 to 3.63; P = .0008) than were the control subjects.

CONCLUSIONS

This study identified psychopharmacologic medication use, corticosteroid use, and hypertension as factors associated with central serous chorioretinopathy. These findings reinforce the concept that stress and adaptations to stress play a role in this disorder. The findings of possible associations between central serous chorioretinopathy and both hypertension and corticosteroid usage suggest that these modifiable factors may influence morbidity of central serous chorioretinopathy.

摘要

目的

确定与中心性浆液性脉络膜视网膜病变相关的全身因素。

方法

在一项回顾性研究中,将在转诊机构接受检查的230例连续性中心性浆液性脉络膜视网膜病变患者与在同一转诊机构接受检查的230例有眼部检查结果、按性别和年龄匹配的历史对照组患者进行比较。

结果

患者的中位年龄为49.8岁,对照组为50.0岁。两组的男女比例均为2.7:1。与对照组相比,中心性浆液性脉络膜视网膜病变患者更有可能使用精神类药物(比值比=2.6;95%置信区间=1.30至5.19;P=0.0049)和皮质类固醇(比值比=3.17;95%置信区间=1.30至7.70;P=0.0067),且更有可能患有高血压(比值比=2.25;95%置信区间=1.39至3.63;P=0.0008)。

结论

本研究确定精神类药物使用、皮质类固醇使用和高血压为与中心性浆液性脉络膜视网膜病变相关的因素。这些发现强化了应激及对应激的适应在该疾病中起作用的概念。中心性浆液性脉络膜视网膜病变与高血压和皮质类固醇使用之间可能存在关联的发现表明,这些可改变的因素可能影响中心性浆液性脉络膜视网膜病变的发病率。

相似文献

1
Systemic findings associated with central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变相关的全身表现。
Am J Ophthalmol. 1999 Jul;128(1):63-8. doi: 10.1016/s0002-9394(99)00075-6.
2
Central serous chorioretinopathy and glucocorticoids.中心性浆液性脉络膜视网膜病变与糖皮质激素
Surv Ophthalmol. 2002 Sep-Oct;47(5):431-48. doi: 10.1016/s0039-6257(02)00338-7.
3
Central serous chorioretinopathy in endogenous hypercortisolism.内源性皮质醇增多症中的中心性浆液性脉络膜视网膜病变
Arch Ophthalmol. 1993 Sep;111(9):1229-33. doi: 10.1001/archopht.1993.01090090081024.
4
Central serous chorioretinopathy after bone marrow transplantation.骨髓移植后中心性浆液性脉络膜视网膜病变
Am J Ophthalmol. 2001 Jun;131(6):804-5. doi: 10.1016/s0002-9394(00)00928-4.
5
Central serous chorioretinopathy complicating systemic corticosteroid therapy.系统性皮质类固醇治疗并发中心性浆液性脉络膜视网膜病变
Eur J Ophthalmol. 1997 Jul-Sep;7(3):297-300. doi: 10.1177/112067219700700317.
6
Risk factors for central serous chorioretinopathy: a case-control study.中心性浆液性脉络膜视网膜病变的危险因素:一项病例对照研究。
Ophthalmology. 2004 Feb;111(2):244-9. doi: 10.1016/j.ophtha.2003.09.024.
7
An association between central serous chorioretinopathy and gastroesophageal reflux disease.中心性浆液性脉络膜视网膜病变与胃食管反流病之间的关联。
Am J Ophthalmol. 2004 Jun;137(6):1096-100. doi: 10.1016/j.ajo.2004.01.054.
8
Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy.
Ophthalmologica. 2004 Mar-Apr;218(2):107-10. doi: 10.1159/000076145.
9
Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study.
Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):800-2. doi: 10.1007/s00417-004-0885-z.
10
Natural course of central serous chorioretinopathy without subretinal exudates in normal pregnancy.正常妊娠中无视网膜下渗出的中心性浆液性脉络膜视网膜病变的自然病程。
Can J Ophthalmol. 2008 Oct;43(5):588-90. doi: 10.3129/i08-097.

引用本文的文献

1
Impact of the COVID-19 pandemic on the incidence and recurrence of central serous chorioretinopathy in Greece: a multicenter study.新冠疫情对希腊中心性浆液性脉络膜视网膜病变发病率和复发率的影响:一项多中心研究
Int Ophthalmol. 2025 Aug 12;45(1):329. doi: 10.1007/s10792-025-03704-1.
2
Association of central serous chorioretinopathy with single-nucleotide polymorphisms in Complement Factor H gene in a Chinese population.中国人群中中心性浆液性脉络膜视网膜病变与补体因子H基因单核苷酸多态性的关联
Int Ophthalmol. 2025 Jul 31;45(1):320. doi: 10.1007/s10792-025-03585-4.
3
Choroidal circulation time by wide-field indocyanine green angiography in central serous chorioretinopathy.
广角吲哚菁绿血管造影术测量中心性浆液性脉络膜视网膜病变的脉络膜循环时间
Jpn J Ophthalmol. 2025 Apr 18. doi: 10.1007/s10384-025-01188-1.
4
Three-Dimensional Characteristics of Choroidal Vasculature Associated With Filling Delay in Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变中与充盈延迟相关的脉络膜血管系统的三维特征
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):33. doi: 10.1167/iovs.66.4.33.
5
Optical Coherence Tomography Study of Choroidal Response to Exercise-Induced Hypertension in Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变中脉络膜对运动诱发高血压反应的光学相干断层扫描研究
J Clin Med. 2024 Nov 1;13(21):6580. doi: 10.3390/jcm13216580.
6
Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy.巩膜厚度对中心性浆液性脉络膜视网膜病变光动力疗法疗效的影响。
Acta Ophthalmol. 2025 May;103(3):e165-e175. doi: 10.1111/aos.16779. Epub 2024 Oct 20.
7
Increased oxidative stress biomarkers in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中氧化应激生物标志物增加。
Sci Rep. 2024 Sep 10;14(1):21099. doi: 10.1038/s41598-024-71890-6.
8
The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects.炎症在中心性浆液性脉络膜视网膜病变中的作用:从机制到治疗前景
Front Pharmacol. 2024 May 21;15:1200492. doi: 10.3389/fphar.2024.1200492. eCollection 2024.
9
Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study.基于光学相干断层扫描的依普利酮治疗慢性中心性浆液性脉络膜视网膜病变的阳性预测指标:一项回顾性研究
Cureus. 2024 Apr 22;16(4):e58791. doi: 10.7759/cureus.58791. eCollection 2024 Apr.
10
Genetic and Clinical Characteristics of Central Serous Chorioretinopathy With Steroid Use.使用类固醇的中心性浆液性脉络膜视网膜病变的遗传和临床特征
Cureus. 2024 Apr 20;16(4):e58631. doi: 10.7759/cureus.58631. eCollection 2024 Apr.